Web Results

en.wikipedia.org/wiki/Omalizumab

Omalizumab, sold under the trade name Xolair, is a medication originally designed to reduce sensitivity to allergens. It has been used to try to control severe ...

www.rxlist.com/xolair-drug.htm

Oct 26, 2016 ... Some people using omalizumab have had a severe, life-threatening allergic reaction to this medication, either right after the injection or hours ...

www.xolair.com/allergic-asthma/how-xolair-works.html

XOLAIR (omalizumab) for subcutaneous use is designed to specifically block IgE. What is XOLAIR? XOLAIR® (omalizumab) for subcutaneous use is an ...

www.xolair.com

XOLAIR (omalizumab) for subcutaneous use is a prescription treatment for moderate to severe persistent allergic asthma and chronic idiopathic urticaria ( CIU) in ...

www.medscape.com/viewarticle/494543

Results: Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human immunoglobulin (Ig)E. Bound IgE is not available for ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC1681435

Jan 27, 2005 ... Results. Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human immunoglobulin (Ig)E. Bound IgE is ...

www.ncbi.nlm.nih.gov/pubmed/21243454

Omalizumab is a humanized, monoclonal anti-IgE antibody that binds specifically to circulating IgE molecules, thus interrupting the allergic cascade.

www.drugbank.ca/drugs/DB00043

Identification. Name, Omalizumab. Accession Number, DB00043 (BTD00081, BIOD00081). Type, Biotech. Groups, Approved, Investigational. Description.

www.medicinenet.com/omalizumab/article.htm

Information about omalizumab (Xolair), an injectable drug prescribed to treat asthma that is not adequately controlled with inhaled steroids.